Company / Working Capital per Share
Arrowhead Pharmaceuticals Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.07
FY2025
5-year range
$2.33 / $6.07
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#92 of 210
Health Care
What the data says
At $6.07, Arrowhead Pharmaceuticals's working capital per share ranks #92 of 210 in the Health Care sector. Working Capital per Share has increased for 4 consecutive years, from $2.33 in FY2021 to $6.07 in FY2025.
Based on SEC 10-K filings.
6.07 in FY2025 with a 5-year CAGR of +15.5%.
Improved from $2.96 to $6.07 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +33.5%
- 5-Year CAGR
- +15.5%
- 10-Year CAGR
- -
Sector benchmark
#92 of 210 in Health CareTop 44% of 210This company $6.07 Sector average $146.86
▼
-95.9% below sector average
Key checks
Key Insights
- Arrowhead Pharmaceuticals's working capital per share has grown for 4 consecutive years.
- In FY2025, working capital per share increased 10.0% year-over-year.
- Ranks #92 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.07 | +10.0% |
| FY2024 | $5.52 | +86.2% |
| FY2023 | $2.96 | +16.1% |
| FY2022 | $2.55 | +9.8% |
| FY2021 | $2.33 | -21.2% |
| FY2020 | $2.95 | +55.2% |
| FY2019 | $1.90 | +114.0% |
| FY2018 | $0.89 | +25.9% |
| FY2017 | $0.71 | -35.2% |
| FY2016 | $1.09 | -31.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026